Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

10-12% of Infertile Women in Mumbai Face Early Ovarian Failure: Nova IVI Fertility
  • India - Hindi


News provided by

Nova Pulse IVF Clinic Pvt. Ltd.

18 May, 2018, 11:00 IST

Share this article

Share toX

Share this article

Share toX

MUMBAI, May 18, 2018 /PRNewswire/ --

Mrs. Shubhangi (name changed on request), a 32-year-old woman who had been married for seven years, consulted Nova IVI Fertility with the complaint of absence of menses since six months. She had undergone some IUI cycles over the last three years but not conceived. An ultrasound was done for her in the very first visit, and her ovarian reserve based on her antral follicle count was found to be very low. The same was confirmed by a hormonal test known as the AMH. She was prescribed two cycles of cyclic estrogen and progesterone tablets to prepare her uterine lining. In the third month, she underwent a Donor Egg ICSI procedure where eggs taken from an anonymous egg donor were fertilised with Shubhangi's husband's sperms. Two embryos were transferred into her uterus, and the pregnancy test was found to be positive 10 days later. She had an uneventful pregnancy and delivered a healthy baby at the end of nine months. 

Premature ovarian failure (POF), also referred to as premature ovarian insufficiency, is a condition where there is a physiological, age-related decrease in the number of eggs in the ovaries, which could impact the chances of pregnancy at a younger age (less than 40 years). Normally, follicles in the ovaries supply women with eggs until around the age of 40 to 45 - the average perimenopausal age when the supply of eggs is used up. In POF cases, women as young as 30 years old are seen with no eggs in the ovaries.

A study conducted by The Institute for Social and Economic Change (ISEC) showed nearly 1-2% of Indian women experienced signs of menopause between 29 and 34 years of age. Additionally, this figure went up to 8% in the case of women between 35 and 39 years of age.

Dr. Sulbha Arora, Fertility Consultant at Nova IVI Fertility, Mumbai, said, "When the ovaries fail, they don't produce normal amounts of oestrogen hormone or release eggs regularly. Lesser number of eggs in the ovaries reduces women's fertility potential and makes it difficult for them to conceive. Well-known and well-documented risk factors exist, and the presence or suspicion of autoimmune disorder should be regarded as an important one. In Mumbai, we see about 10-12% of women under the age of 36 who come to us with difficulties in conceiving suffer from low ovarian reserve or premature ovarian failure."

Causes and symptoms 

Lifestyle changes such as smoking, unmonitored contraceptive pill use, previous ovarian surgeries, anticancer therapies and familial POF are some of the known reasons for low ovarian reserve at a rather young age. X chromosome abnormalities, autosomal causes, galactosemia, autoimmune disorders, cancer treatment, Turner's syndrome, enzyme defects, and environmental toxins are some other factors leading to early menopause. In many cases, the cause cannot be found (idiopathic).

Premature ovarian failure is to some degree predictable in its occurrence and should be considered when young women encounter a loss of menstrual regularity. At times, a woman may get normal periods for a few months and then skip it for the next few months. They may also have other symptoms of early menopause like hot flashes, night sweats, sleeping problems, anxiety, mood swings, vaginal dryness, energy loss, low sex drive, painful sex, and bladder control problems.

Depending on the cause, POF may develop as early as the teen years or the problem may have been present from birth. It is difficult, though not impossible, for women who have premature ovarian insufficiency to become pregnant.

Treatment options 

"Unfortunately, there is no treatment for POF and the effects of age on declining ovarian reserve cannot be reversed. Hormonal changes due to declining oestrogen levels can be treated, however, fertility cannot be restored in most of these cases. If the reserve is low but not yet completely depleted, women can attempt a self-cycle of ICSI with maximum safe dose of gonadotrophins and use of adjuvants like growth hormone, DHEAS albeit with dubious chances of success. Donor egg IVF is the ideal treatment option in such cases, and the only treatment option after established ovarian failure," added Dr. Arora.

Women with POF should be educated about the condition, given counselling and psychological support as they are at high risk of moderate to severe depression, especially those with infertility. Hormone replacement therapy is mandatory for these women because they are at an increased risk of developing osteoporosis, cardiovascular disorders and coronary heart diseases. General measures like increased physical activity, calcium rich diet, vitamin D supplementation, avoidance of cigarette smoking should be discussed. For women who desire parenthood after exhaustion of treatments for biological gametes, oocyte donation or adoption can be suggested.

In a country with a population of 1.2 billion, it is estimated that a whopping 30 million couples suffer from infertility. What is even more worrying is the rising incidence of young women facing infertility. A condition which was predominantly seen among older couples, infertility is now seen more frequently seen in women who are younger than 35 years of age.

About Nova IVI Fertility 

Nova IVI Fertility (NIF) is the among the largest service providers in the fertility space. NIF aims to bring advanced Assisted Reproductive Technology (ART) to India in partnership with IVI of Spain. The partnership has resulted in a substantial addition to Nova's IVF services and technology, including proprietary software, training, and quality management. With IVI's know-how and vast international expertise, NIF brings the same exceptional standard of processes, protocols, and policies to India.

In addition to providing core procedures such as IUI, IVF, and Andrology services, NIF offers several state-of-the-art technologies such as Vitrification for preserving embryos and eggs, ERA to find out the timing of the uterus' capacity to accept embryos, PGS and PGD for the transfer of genetically normal embryos - all procedures that significantly improve the chances of a pregnancy following IVF-ICSI, even in patients with multiple previous failures. NIF currently operates 20 fertility centres in India (Ahmedabad (2), Bengaluru (3), Chennai, Coimbatore, Hisar, Hyderabad, Indore, Jalandhar, Kolkata, Lucknow, Mumbai (2), New Delhi (2), Pune, Surat, and Vijayawada).

For further information, visit http://www.novaivifertility.com

Media Contact:
Raghavi R
[email protected]
+91(80)67680615
Assistant Manager
PR
Nova IVI Fertility

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.